Article
CRISPR-Cas9 screening of KSHV-transformed cells identifies XPO1 as a vulnerable target of…
medRxiv · 2019 · Gruffaz, M.; Yuan, H.; Meng, W.; Liu, H.; Bae, S.; Kim, J. S.; Lu, C.; Huang, Y.; Gao, S.-J.
Key facts
| Title | CRISPR-Cas9 screening of KSHV-transformed cells identifies XPO1 as a vulnerable target of cancer cells |
|---|---|
| First author | Gruffaz, M.; Yuan, H.; Meng, W.; Liu, H.; Bae, S.; Kim, J. S.; Lu, C.; Huang, Y.; Gao, S.-J. |
| Journal | medRxiv |
| Published | Apr 6, 2019 |
| DOI | 10.1101/601369 |
| Devices mentioned | BK110039, DEN000008, K823719 |
| Product codes mentioned | HKI, NDS, PCA, KIP, KIT, LXG, PFT |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1